Literature DB >> 11731278

Myopathy with lobulated muscle fibers: evidence for heterogeneous etiology and clinical presentation.

D Figarella-Branger1, M El-Dassouki, A Saenz, A M Cobo, P Malzac, S Tong, E Cassotte, J P Azulay, J Pouget, J F Pellissier.   

Abstract

The clinico-pathological features of 17 patients displaying a myopathy with lobulated (trabeculated) fibers are reported. All these patients had a limb girdle phenotype and at least 20% of lobulated fibers in their muscle biopsies. There were ten females and seven males. The onset of symptoms ranged from 2 to 55 years (mean 24). The average age at the time of muscle biopsy was 39 (range 3-63). Interestingly, in six patients, high prevalence of lobulated fibers was observed at the second biopsy only, performed on average 11 years after the first or in another muscle. Six patients had a suggestively positive family history. Facial weakness was noted in two patients (genetic study confirmed FSH dystrophy). The course and the severity of weakness varied from one patient to another. Immunohistochemistry and Western blot analyses revealed one Duchenne carrier, one alpha-sarcoglycanopathy, no dysferlinopathy and four calpain deficiencies (including one patient with FSH dystrophy), but SSCP revealed mutation in the calpain gene in only one of the patients. These results show that (1) myopathies with lobulated fibers are clinically and genetically heterogeneous, (2) lack of calpain expression by Western blot analysis is not always associated with null mutation, (3) a molecular diagnosis is made in less than 40% of myopathy with lobulated fibers, (4) when observed, lobulated fibers are most prominent in proximal muscles and require time to appear.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11731278     DOI: 10.1016/s0960-8966(01)00245-0

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  6 in total

1.  Association of a Novel ACTA1 Mutation With a Dominant Progressive Scapuloperoneal Myopathy in an Extended Family.

Authors:  Kristen Zukosky; Katherine Meilleur; Bryan J Traynor; Jahannaz Dastgir; Livija Medne; Marcella Devoto; James Collins; Jachinta Rooney; Yaqun Zou; Michele L Yang; J Raphael Gibbs; Markus Meier; Joerg Stetefeld; Richard S Finkel; Joachim Schessl; Lauren Elman; Kevin Felice; Toby A Ferguson; Ozge Ceyhan-Birsoy; Alan H Beggs; Gihan Tennekoon; Janel O Johnson; Carsten G Bönnemann
Journal:  JAMA Neurol       Date:  2015-06       Impact factor: 18.302

2.  Chronic administration of a leupeptin-derived calpain inhibitor fails to ameliorate severe muscle pathology in a canine model of duchenne muscular dystrophy.

Authors:  Martin K Childers; Janet R Bogan; Daniel J Bogan; Hansel Greiner; Melanie Holder; Robert W Grange; Joe N Kornegay
Journal:  Front Pharmacol       Date:  2012-01-09       Impact factor: 5.810

3.  Myopathy associated with homozygous PYROXD1 pathogenic variants detected by genome sequencing.

Authors:  Jeremy D Woods; Negar Khanlou; Hane Lee; Rebecca Signer; Perry Shieh; Johnathan Chen; Matthew Herzog; Christina Palmer; Julian Martinez-Agosto; Stanley F Nelson
Journal:  Neuropathology       Date:  2020-02-09       Impact factor: 1.906

4.  Progression to Loss of Ambulation Among Patients with Autosomal Recessive Limb-girdle Muscular Dystrophy: A Systematic Review.

Authors:  Ivana F Audhya; Antoinette Cheung; Shelagh M Szabo; Emma Flint; Conrad C Weihl; Katherine L Gooch
Journal:  J Neuromuscul Dis       Date:  2022

5.  Gene expression profiling in limb-girdle muscular dystrophy 2A.

Authors:  Amets Sáenz; Margarita Azpitarte; Rubén Armañanzas; France Leturcq; Ainhoa Alzualde; Iñaki Inza; Federico García-Bragado; Gaspar De la Herran; Julián Corcuera; Ana Cabello; Carmen Navarro; Carolina De la Torre; Eduard Gallardo; Isabel Illa; Adolfo López de Munain
Journal:  PLoS One       Date:  2008-11-18       Impact factor: 3.240

6.  Membrane Repair Deficit in Facioscapulohumeral Muscular Dystrophy.

Authors:  Adam J Bittel; Sen Chandra Sreetama; Daniel C Bittel; Adam Horn; James S Novak; Toshifumi Yokota; Aiping Zhang; Rika Maruyama; Kenji Rowel Q Lim; Jyoti K Jaiswal; Yi-Wen Chen
Journal:  Int J Mol Sci       Date:  2020-08-04       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.